JAMP PHARMA

JAMP Pharma Group is a private Canadian company that was launched in 1988. Originally a contract manufacturing organization 1 (CMO), the company now provides high-quality medicines and health solutions for patients and consumers... The JAMP Pharma Group launches Apremilast, a specialty generic, offering a more affordable alternative to the reference product Otezla® (marketed by Amgen Canada Inc.). The JAMP Pharma Group, a leader in product launches1, expands its line of specialty products, contributing to its ambition to offer healthcare professionals and patients services…

Also known as: JAMP, JAMP Pharma Corporation, JAMP Pharma Group

Primary location: Québec Canada